Microglia are required for astroglial toll-like receptor 4 response and for optimal TLR2 and TLR3 response

GLIA

Volumn 60, Issue 4, 2012, Pages 630-638

  Holm, Thomas H ^a   Draeby, Dina ^a   Owens, Trevor ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Astrocytes; Co culture; Microglia; Signaling; Toll like receptors

Indexed keywords

CD14 ANTIGEN; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; CELL ADHESION; CELL CULTURE; CELL LINEAGE; CELL STIMULATION; CONTROLLED STUDY; FLOW CYTOMETRY; IMMUNOFLUORESCENCE; MICROGLIA; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL;

ANIMALS; ANIMALS, NEWBORN; ANTIGENS, CD; ANTIGENS, CD11B; ASTROCYTES; BRAIN; CELLS, CULTURED; CHEMOKINE CCL2; COCULTURE TECHNIQUES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMINE; INTERFERON INDUCERS; INTERLEUKIN-1BETA; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROGLIA; ORGANOMETALLIC COMPOUNDS; POLY I-C; POLYSACCHARIDES; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 3; TOLL-LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84856739147     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22296     Document Type: Article

References (48)

1. Babcock AA, Kuziel WA, Rivest S, Owens T. 2003. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J Neurosci 23: 7922-7930.
2. Babcock AA, Wirenfeldt M, Holm T, Nielsen HH, Dissing-Olesen L, Toft-Hansen H, Millward JM, Landmann R, Rivest S, Finsen B, Owens T. 2006. Toll-like receptor 2 signaling in response to brain injury: An innate bridge to neuroinflammation. J Neurosci 26: 12826-12837.
3. Bechmann I, Galea I, Perry VH. 2007. What is the blood-brain barrier (not)? Trends Immunol 28: 5-11.
4. Bowdish DM, Sakamoto K, Kim MJ, Kroos M, Mukhopadhyay S, Leifer CA, Tryggvason K, Gordon S, Russell DG. 2009. MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. PLoS Pathog 5: e1000474.
5. Bowman CC, Rasley A, Tranguch SL, Marriott I. 2003. Cultured astrocytes express toll-like receptors for bacterial products. Glia 43: 281-291.
6. Bsibsi M, Ravid R, Gveric D, van Noort JM. 2002. Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 61: 1013-1021.
7. Carpentier PA, Begolka WS, Olson JK, Elhofy A, Karpus WJ, Miller SD. 2005. Differential activation of astrocytes by innate and adaptive immune stimuli. Glia 49: 360-374.
8. Crocker SJ, Frausto RF, Whitton JL, Milner R. 2008. A novel method to establish microglia-free astrocyte cultures: Comparison of matrix metalloproteinase expression profiles in pure cultures of astrocytes and microglia. Glia 56: 1187-1198.
9. da Silva Correia J, Soldau K, Christen U, Tobias PS, Ulevitch RJ. 2001. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2. J Biol Chem 276: 21129-21135.
10. Esen N, Shuffield D, Syed MM, Kielian T. 2007. Modulation of connexin expression and gap junction communication in astrocytes by the gram-positive bacterium S. aureus. Glia 55: 104-117.
11. Esen N, Tanga FY, DeLeo JA, Kielian T. 2004. Toll-like receptor 2 (TLR2) mediates astrocyte activation in response to the Gram-positive bacterium Staphylococcus aureus. J Neurochem 88: 746-758.
12. Falsig J, Latta M, Leist M. 2004a. Defined inflammatory states in astrocyte cultures: Correlation with susceptibility towards CD95-driven apoptosis. J Neurochem 88: 181-193.
13. Falsig J, Porzgen P, Lotharius J, Leist M. 2004b. Specific modulation of astrocyte inflammation by inhibition of mixed lineage kinases with CEP-1347. J Immunol 173: 2762-2770.
14. Falsig J, Porzgen P, Lund S, Schrattenholz A, Leist M. 2006. The inflammatory transcriptome of reactive murine astrocytes and implications for their innate immune function. J Neurochem 96: 893-907.
15. Farina C, Krumbholz M, Giese T, Hartmann G, Aloisi F, Meinl E. 2005. Preferential expression and function of Toll-like receptor 3 in human astrocytes. J Neuroimmunol 159: 12-19.
16. Faure E, Thomas L, Xu H, Medvedev A, Equils O, Arditi M. 2001. Bacterial lipopolysaccharide and IFN-gamma induce Toll-like receptor 2 and Toll-like receptor 4 expression in human endothelial cells: Role of NF-kappa B activation. J Immunol 166: 2018-2024.
17. Finberg RW, Kurt-Jones EA. 2006. CD14: Chaperone or matchmaker? Immunity 24: 127-129.
18. Fischer G, Kettenmann H. 1985. Cultured astrocytes form a syncytium after maturation. Exp Cell Res 159: 273-279.
19. Froes MM, de Carvalho AC. 1998. Gap junction-mediated loops of neuronal-glial interactions. Glia 24: 97-107.
20. Fuchtbauer L, Groth-Rasmussen M, Holm TH, Lobner M, Toft-Hansen H, Khorooshi R, Owens T. 2011. Angiotensin II Type 1 receptor (AT1) signaling in astrocytes regulates synaptic degeneration-induced leukocyte entry to the central nervous system. Brain Behav Immun 25: 897-904.
21. Fuchtbauer L, Toft-Hansen H, Khorooshi R, Owens T. 2010. Expression of astrocytic type 2 angiotensin receptor in central nervous system inflammation correlates with blood-brain barrier breakdown. J Mol Neurosci 42: 89-98.
22. Giulian D, Baker TJ. 1986. Characterization of ameboid microglia isolated from developing mammalian brain. J Neurosci 6: 2163-2178.
23. Hamby ME, Uliasz TF, Hewett SJ, Hewett JA. 2006. Characterization of an improved procedure for the removal of microglia from confluent monolayers of primary astrocytes. J Neurosci Methods 150: 128-137.
24. Hanisch UK, Kettenmann H. 2007. Microglia: Active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci 10: 1387-1394.
25. Hansson E, Ronnback L. 2003. Glial neuronal signaling in the central nervous system. FASEB J 17: 341-348.
26. Heppner FL, Greter M, Marino D, Falsig J, Raivich G, Hovelmeyer N, Waisman A, Rulicke T, Prinz M, Priller J, Becher B, Aguzzi A. 2005. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med 11: 146-152.
27. Kawai T, Akira S. 2010. The role of pattern-recognition receptors in innate immunity: Update on Toll-like receptors. Nat Immunol 11: 373-384.
28. Khorooshi R, Babcock AA, Owens T. 2008. NF-kappaB-driven STAT2 and CCL2 expression in astrocytes in response to brain injury. J Immunol 181: 7284-7291.
29. Kielian T. 2006. Toll-like receptors in central nervous system glial inflammation and homeostasis. J Neurosci Res 83: 711-730.
30. Lehnardt S, Schott E, Trimbuch T, Laubisch D, Krueger C, Wulczyn G, Nitsch R, Weber JR. 2008. A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS. J Neurosci 28: 2320-2331.
31. Mishra BB, Mishra PK, Teale JM. 2006. Expression and distribution of Toll-like receptors in the brain during murine neurocysticercosis. J Neuroimmunol 181: 46-56.
32. Montero M, Gonzalez B, Zimmer J. 2009. Immunotoxic depletion of microglia in mouse hippocampal slice cultures enhances ischemia-like neurodegeneration. Brain Res 1291: 140-152.
33. Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M, Nakanishi K, Kimoto M, Miyake K, Takeda K, Akira S. 2000. Cutting edge: Endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J Immunol 164: 3476-3479.
34. Owens T. 2009. Toll-like receptors in neurodegeneration. Curr Top Microbiol Immunol 336: 105-120.
35. Owens T, Babcock AA, Millward JM, Toft-Hansen H. 2005. Cytokine and chemokine inter-regulation in the inflamed or injured CNS. Brain Res Brain Res Rev 48: 178-184.
36. Park SK, Murphy S. 1994. Duration of expression of inducible nitric oxide synthase in glial cells. J Neurosci Res 39: 405-411.
37. Phulwani NK, Esen N, Syed MM, Kielian T. 2008. TLR2 expression in astrocytes is induced by TNF-alpha- and NF-kappa B-dependent pathways. J Immunol 181: 3841-3849.
38. Rivest S. 2003. Molecular insights on the cerebral innate immune system. Brain Behav Immun 17: 13-19.
39. Saura J. 2007. Microglial cells in astroglial cultures: A cautionary note. J Neuroinflamm 4: 26.
40. Schrijver IA, van Meurs M, Melief MJ, Wim Ang C, Buljevac D, Ravid R, Hazenberg MP, Laman JD. 2001. Bacterial peptidoglycan and immune reactivity in the central nervous system in multiple sclerosis. Brain 124: 1544-1554.
41. Simmons ML, Murphy S. 1992. Induction of nitric oxide synthase in glial cells. J Neurochem 59: 897-905.
42. Sola C, Casal C, Tusell JM, Serratosa J. 2002. Astrocytes enhance lipopolysaccharide-induced nitric oxide production by microglial cells. Eur J Neurosci 16: 1275-1283.
43. Thiele DL, Kurosaka M, Lipsky PE. 1983. Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: Delineation by its sensitivity to the lysosomotropic agent, L-leucine methyl ester. J Immunol 131: 2282-2290.
44. Toft-Hansen H, Fuchtbauer L, Owens T. 2011. Inhibition of reactive astrocytosis in established experimental autoimmune encephalomyelitis favors infiltration by myeloid cells over T cells and enhances severity of disease. Glia 59: 166-176.
45. Voskuhl RR, Peterson RS, Song B, Ao Y, Morales LB, Tiwari-Woodruff S, Sofroniew MV. 2009. Reactive astrocytes form scar-like perivascular barriers to leukocytes during adaptive immune inflammation of the CNS. J Neurosci 29: 11511-11522.
46. Wainwright DA, Xin J, Mesnard NA, Sanders VM, Jones KJ. 2010. Toll-like receptor 2 and facial motoneuron survival after facial nerve axotomy. Neurosci Lett 471: 10-14.
47. Wang T, Lafuse WP, Zwilling BS. 2000. Regulation of toll-like receptor 2 expression by macrophages following Mycobacterium avium infection. J Immunol 165: 6308-6313.
48. Ziegler-Heitbrock HW. 1995. Molecular mechanism in tolerance to lipopolysaccharide. J Inflamm 45: 13-26.